This Article Full Text Full Text (PDF) All Versions of this Article: 37/10/2601    most recent 01.STR.0000240407.14765.e8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, F. Articles by Yang, G.-Y. Search for Related Content PubMed PubMed Citation Articles by Shen, F. Articles by Yang, G.-Y. Related Collections Acute Cerebral Infarction Neuroprotectors

(Stroke. 2006;37:2601.)
© 2006 American Heart Association, Inc.

Original Contributions

Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury After Focal Cerebral Ischemia in Mice

Fanxia Shen, MD; Hua Su, MD; Yongfeng Fan, MD, PhD; Yongmei Chen, MD, PhD; Yiqian Zhu, MD; Weizhong Liu, MD; William L. Young, MD Guo-Yuan Yang, MD, PhD

From the Departments of Anesthesia and Perioperative Care (F.S., Y.F., Y.C., Y.Z., W.L., W.L.Y., G.-Y.Y.), Neurological Surgery (W.L.Y., G.-Y.Y.), Neurology (W.L.Y.), and Internal Medicine (H.S.), Center for Cerebrovascular Research, University of California, San Francisco, Calif; and the Department of Neurology (F.S., G.-Y.Y.), RuiJin Hospital, Jiaotong University, Shanghai, China.

Correspondence to Guo-Yuan Yang, MD, PhD, University of California, San Francisco, Department of Anesthesia and Perioperative Care, 1001 Potrero Ave., Rm. 3C-38, San Francisco, CA 94110. E-mail gyyang{at}anesthesia.ucsf.edu

Background and Purpose— Exogenous delivery of vascular endothelial growth factor gene (VEGF) may provide a useful approach to the treatment of brain ischemia. We investigated the use of a hypoxia-responsive element to control VEGF expression given for neuroprotection.

Methods— Three groups (n=36) of mice received AAVH9-VEGF, AAVH9-lacZ, or saline injection. Five days after gene transfer, the mice underwent 45 minutes of transient middle cerebral artery occlusion (tMCAO) followed by 1 to 7 days of reperfusion. Infarct volume was determined using cresyl violet staining; neuronal injury was examined using TUNEL, cleaved caspase-3, and fluoro-Jade B staining.

Results— Hypoxia-inducible factor-1 (HIF-1) was overexpressed after tMCAO in the ischemic hemisphere in the brain. Expression of lacZ, mediated by AAV-lacZ, was seen before and after tMCAO; however, AAVH9-lacZ-mediated lacZ expression was detected only after tMCAO. Infarct volume was smaller in the AAVH9-VEGF-transduced group compared with AAVH9-lacZ and saline groups (55% reduction, P<0.05) with reduced TUNEL (29±5% and 30±7% versus 12±3%, P<0.05), cleaved caspase-3 (20±3% and 21±5% versus 13±4%, P<0.05) and fluoro-Jade B (23±3% and 24±5% versus 12±5%, P<0.05) -positive neurons, respectively.

Conclusion— Exogenous expression of VEGF through AAVH9-VEGF gene transfer 5 days before the onset of ischemia provides neuroprotection. Hypoxia-responsive element is a viable strategy of restricting VEGF expression to areas of ischemia to minimize adverse effects of therapy on adjacent normal parenchyma.

Key Words: adeno-associated virus • brain • hypoxia-responsive element • ischemia • neuroprotection • VEGF

This article has been cited by other articles:

				C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF]

				W. Zhu, Y. Fan, T. Frenzel, M. Gasmi, R. T. Bartus, W. L. Young, G.-Y. Yang, and Y. Chen Insulin Growth Factor-1 Gene Transfer Enhances Neurovascular Remodeling and Improves Long-Term Stroke Outcome in Mice Stroke, April 1, 2008; 39(4): 1254 - 1261. [Abstract] [Full Text] [PDF]